AI Article Synopsis

  • The COVID-19 pandemic has impacted the spread of non-SARS-CoV-2 respiratory viruses, leading to a study that used wastewater surveillance to monitor SARS-CoV-2 and influenza A virus in three major Chinese port cities.
  • Researchers employed a novel machine learning algorithm that combined Gaussian and random forest models to predict the trends of these infections, revealing two waves of SARS-CoV-2 in mid-2023 and two waves of influenza A.
  • Their predictions from October 2023 to April 2024 closely matched observed data, indicating that combining wastewater surveillance with machine learning can significantly enhance public health responses to respiratory viral diseases.

Article Abstract

The COVID-19 pandemic has altered the circulation of non-SARS-CoV-2 respiratory viruses. In this study, we carried out wastewater surveillance of SARS-CoV-2 and influenza A virus (IAV) in three key port cities in China through real-time quantitative PCR (RT-qPCR). Next, a novel machine learning algorithm (MLA) based on Gaussian model and random forest model was used to predict the epidemic trajectories of SARS-CoV-2 and IAV. The results showed that from February 2023 to January 2024, three port cities experienced two waves of SARS-CoV-2 infection, which peaked in late-May and late-August 2023, respectively. Two waves of IAV were observed in the spring and winter of 2023, respectively with considerable variations in terms of onset/offset date and duration. Furthermore, we employed MLA to extract the key features of epidemic trajectories of SARS-CoV-2 and IAV from February 3rd, to October 15th, 2023, and thereby predicted the epidemic trends of SARS-CoV-2 and IAV from October 16th, 2023 to April 22nd, 2024, which showed high consistency with the observed values. These collective findings offer an important understanding of SARS-CoV-2 and IAV epidemics, suggesting that wastewater surveillance together with MLA emerges as a powerful tool for risk assessment of respiratory viral diseases and improving public health preparedness.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scitotenv.2024.175830DOI Listing

Publication Analysis

Top Keywords

sars-cov-2 iav
16
epidemic trajectories
12
trajectories sars-cov-2
12
sars-cov-2 influenza
8
influenza virus
8
novel machine
8
machine learning
8
learning algorithm
8
wastewater surveillance
8
port cities
8

Similar Publications

Biocompatible Iron Oxide Nanoparticles Display Antiviral Activity Against Two Different Respiratory Viruses in Mice.

Int J Nanomedicine

December 2024

Department of Immunology, Oncology and Nanobiomedicine Initiative, Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain.

Background: Severe Acute Respiratory syndrome coronavirus 2 (SARS-CoV-2) and Influenza A viruses (IAVs) are among the most important causes of viral respiratory tract infections, causing similar symptoms. IAV and SARS-CoV-2 infections can provoke mild symptoms like fever, cough, sore throat, loss of taste or smell, or they may cause more severe consequences leading to pneumonia, acute respiratory distress syndrome or even death. While treatments for IAV and SARS-CoV-2 infection are available, IAV antivirals often target viral proteins facilitating the emergence of drug-resistant viral variants.

View Article and Find Full Text PDF

Rapid and sensitive diagnostic measures are a pre-requisite for the control of SARS-CoV-2 outbreaks. Dogs detect SARS-CoV-2-infected human individuals with high speed due to their extraordinary olfactory acuity. In the post-pandemic phase of SARS-CoV-2 it is difficult to obtain samples from infected humans for scent dog training.

View Article and Find Full Text PDF

Revealr-Based Diagnostic Panel for Rapid Detection of Acute Respiratory Infections.

ACS Synth Biol

December 2024

Department of Pharmaceutical Sciences, University of California, Irvine, California 92697-3958, United States.

RNA-encoded viral nucleic acid analyte reporter (REVEALR) is a rapid and highly sensitive point-of-care diagnostic developed for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection, genotyping, and quantification. Here, we extend the breadth of this nucleic acid technology to include a viral respiratory panel that can detect low attomolar levels of influenza A (IAV), influenza B (IBV), SARS-CoV-2 (CoV2), and the respiratory syncytial virus (RSV). Of 39 clinical samples collected at the UCI Medical Center in Orange, California, the extended REVEALR panel showed a positive predictive agreement and negative predictive agreement of 100% for IAV, CoV2, and RSV in sequence-verified clinical samples, with 0 false positive results.

View Article and Find Full Text PDF
Article Synopsis
  • The zoonotic transmission of influenza A viruses (IAVs) and coronaviruses (CoVs) can lead to severe diseases, and the cleavage of glycoproteins is essential for their infectivity.
  • The study focused on the role of transmembrane serine protease 2 (TMPRSS2) in cleaving viral proteins in human airway cells and its dependency for different IAV and CoV strains.
  • Results showed that while TMPRSS2 is crucial for the activation of certain viruses like H1N1/1918 and MERS-CoV, others like SARS-CoV and some IAV subtypes show less dependency, indicating the potential for alternative proteases and highlighting TMPRSS2 as
View Article and Find Full Text PDF

Respiratory Viral Infection Patterns in Hospitalised Children Before and After COVID-19 in Hong Kong.

Viruses

November 2024

Department of Paediatrics, Faculty of Medicine, The Chinese University of Hong Kong (CUHK), 6/F Lui Che Woo Clinical Sciences Building, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, China.

Unlabelled: The study highlights the significant changes in respiratory virus epidemiology following the lifting of COVID-19 restrictions.

Method: In this single-centre retrospective study, the virological readouts of adenovirus (AdV), influenza virus A (IAV), influenza virus B (IBV), parainfluenza viruses (PIV) 1, 2, 3, 4, respiratory syncytial virus (RSV), and coupled enterovirus and rhinovirus (EV/RV) were extracted from the respiratory specimens of paediatric patients in Hong Kong from January 2015 to February 2024. The subjects were stratified into five age groups.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!